---
schema_version: "secwatch.filing_event.v1"
accession: "0001609550-23-000008"
form_type: "8-K"
ticker: "INSP"
cik: "0001609550"
company_name: "Inspire Medical Systems, Inc."
filed_at: "2023-01-09T23:59:59+00:00"
generated_at: "2026-06-20T17:52:16.709027+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Inspire Medical Q4 preliminary revenue ~$137.7M (+76% YoY); FY22 ~$407.7M (+75%)

## Summary
- Q4 2022 preliminary revenue $137.5M-$137.9M, ~76% YoY increase.
- Full-year 2022 revenue $407.5M-$407.9M, ~75% increase over FY 2021.
- Activated 61 new U.S. implant centers in Q4 (total 905); added 16 sales territories (total 225).
- European revenue growth driven by Germany, Switzerland, and the Netherlands.
- Published inaugural Environmental, Social, and Governance (ESG) report.

## SEC filing metadata
- accession: 0001609550-23-000008
- form_type: 8-K
- ticker: INSP
- cik: 0001609550
- company_name: Inspire Medical Systems, Inc.
- filed_at: 2023-01-09T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1609550/000160955023000008/0001609550-23-000008-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1609550/000160955023000008/insp-20230109.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001609550-23-000008
- JSON: https://secwatch.observer/filing/0001609550-23-000008.json
- Plain text: https://secwatch.observer/filing/0001609550-23-000008.txt

## Key facts
- Earnings Releases
  Inspire Medical Systems, Inc. reported preliminary financial results for quarter and full year ended December 31, 2022.
  - Period: quarter and full year ended December 31, 2022
  - Result: preliminary results
  source text: On January 9, 2023, Inspire Medical Systems, Inc. (the “Company”) issued a press release announcing certain preliminary and unaudited results for the quarter and full year ended December 31, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1609550/000160955023000008/0001609550-23-000008-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.